These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 10636127)
1. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Choi YC; Dalakas MC Neurology; 2000 Jan; 54(1):65-71. PubMed ID: 10636127 [TBL] [Abstract][Full Text] [Related]
2. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. Murata K; Dalakas MC Am J Pathol; 1999 Aug; 155(2):453-60. PubMed ID: 10433938 [TBL] [Abstract][Full Text] [Related]
4. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects]. Eymard B Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270 [TBL] [Abstract][Full Text] [Related]
5. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis. Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335 [TBL] [Abstract][Full Text] [Related]
6. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages. De Paepe B; Creus KK; Martin JJ; Weis J; De Bleecker JL Ann N Y Acad Sci; 2009 Sep; 1173():463-9. PubMed ID: 19758187 [TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy. Das L; Blumbergs PC; Manavis J; Limaye VS Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):539-42. PubMed ID: 23343957 [TBL] [Abstract][Full Text] [Related]
8. Immunolocalization of FAS and FAS ligand in inflammatory myopathies. De Bleecker JL; Meire VI; Van Walleghem IE; Groessens IM; Schröder JM Acta Neuropathol; 2001 Jun; 101(6):572-8. PubMed ID: 11515785 [TBL] [Abstract][Full Text] [Related]
9. Expression of specific matrix metalloproteinases in inflammatory myopathies. Kieseier BC; Schneider C; Clements JM; Gearing AJ; Gold R; Toyka KV; Hartung HP Brain; 2001 Feb; 124(Pt 2):341-51. PubMed ID: 11157561 [TBL] [Abstract][Full Text] [Related]
10. Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle. Schmidt J; Barthel K; Wrede A; Salajegheh M; Bähr M; Dalakas MC Brain; 2008 May; 131(Pt 5):1228-40. PubMed ID: 18420712 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes. Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898 [TBL] [Abstract][Full Text] [Related]
12. Specific matrix metalloproteinase expression in focal myositis: an immunopathological study. Rodolico C; Mazzeo A; Toscano A; Messina S; Aguennouz M; Gaeta M; Messina C; Vita G Acta Neurol Scand; 2005 Sep; 112(3):173-7. PubMed ID: 16097959 [TBL] [Abstract][Full Text] [Related]
13. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity. Schmidt J; Rakocevic G; Raju R; Dalakas MC Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591 [TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies. Englund P; Lindroos E; Nennesmo I; Klareskog L; Lundberg IE Am J Pathol; 2001 Oct; 159(4):1263-73. PubMed ID: 11583954 [TBL] [Abstract][Full Text] [Related]
15. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies. Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117 [TBL] [Abstract][Full Text] [Related]
16. Cytochrome c oxidase deficiencies in the muscle of patients with inflammatory myopathies. Chariot P; Ruet E; Authier FJ; Labes D; Poron F; Gherardi R Acta Neuropathol; 1996; 91(5):530-6. PubMed ID: 8740235 [TBL] [Abstract][Full Text] [Related]
17. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Lundberg I; Ulfgren AK; Nyberg P; Andersson U; Klareskog L Arthritis Rheum; 1997 May; 40(5):865-74. PubMed ID: 9153548 [TBL] [Abstract][Full Text] [Related]
18. Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis. Vattemi G; Nogalska A; King Engel W; D'Agostino C; Checler F; Askanas V Acta Neuropathol; 2009 May; 117(5):569-74. PubMed ID: 19280202 [TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex class I expression can be used as a diagnostic tool to differentiate idiopathic inflammatory myopathies from dystrophies. Sundaram C; Uppin MS; Meena AK Neurol India; 2008; 56(3):363-7. PubMed ID: 18974565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]